NORTHERN TRUST CORP - OCUPHIRE PHARMA INC ownership

OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 36 filers reported holding OCUPHIRE PHARMA INC in Q4 2022. The put-call ratio across all filers is 3.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of OCUPHIRE PHARMA INC
ValueSharesWeighting
Q3 2023$103,415
-23.5%
30,870
-1.0%
0.00%
Q2 2023$135,265
+12.5%
31,167
-2.8%
0.00%
Q1 2023$120,263
+52.9%
32,070
+43.9%
0.00%
Q4 2022$78,652
+74.8%
22,2810.0%0.00%
Q3 2022$45,000
+4.7%
22,2810.0%0.00%
Q2 2022$43,000
-35.8%
22,281
+7.4%
0.00%
Q1 2022$67,000
-13.0%
20,746
+0.7%
0.00%
Q4 2021$77,000
+24.2%
20,596
+69.8%
0.00%
Q3 2021$62,00012,1310.00%
Other shareholders
OCUPHIRE PHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
Richmond Brothers, Inc. 368,003$1,232,8122.32%
Knoll Capital Management, LLC 100,000$335,0000.35%
RICE HALL JAMES & ASSOCIATES, LLC 828,628$2,775,9040.18%
Diametric Capital, LP 56,059$187,7970.08%
THOMPSON DAVIS & CO., INC. 17,000$56,9500.07%
MAI Capital Management 455,677$1,526,5180.02%
TRUST CO OF TOLEDO NA /OH/ 30,963$103,7260.02%
BEDEL FINANCIAL CONSULTING INC 15,000$50,2500.01%
Legato Capital Management LLC 10,098$33,8280.01%
Stokes Family Office, LLC 13,030$43,6510.01%
View complete list of OCUPHIRE PHARMA INC shareholders